Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.
Kinney
William A
WA
Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development, Welsh and McKean Roads, Spring House, PA 19477-0776, USA. Wkinney1@prius.jnj.com
Almond
Harold R
HR
Qi
Jenson
J
Smith
Charles E
CE
Santulli
Rosemary J
RJ
de Garavilla
Lawrence
L
Andrade-Gordon
Patricia
P
Cho
Daniel S
DS
Everson
Anita M
AM
Feinstein
Mark A
MA
Leung
Perry A
PA
Maryanoff
Bruce E
BE
D000595:Amino Acid Sequence; D000818:Animals; D015195:Drug Design; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D011487:Protein Conformation; D011956:Receptors, Cell Surface / Q000737:chemistry* / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled; D014579:Urotensins / Q000819:agonists / Q000737:chemistry* / Q000378:metabolism; D014662:Vasoconstrictor Agents / Q000737:chemistry*
D008024:Ligands; D010446:Peptide Fragments; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C121697:UTS2R protein, human; D014579:Urotensins; D014662:Vasoconstrictor Agents; C029677:urotensin II